Neoadjuvant (induction) erlotinib response in stage IIIA non-small-cell lung cancer

被引:22
作者
Kappers, Ingrid [1 ]
Klomp, Houke M. [1 ]
Burgers, Jacobus A. [2 ]
Van Zandwijk, Nico [2 ]
Haas, Rick L. M. [3 ]
van Pel, Renee [4 ]
机构
[1] Antoni Van Leeuwenhoek Hosp, Netherlands Canc Inst, Dept Surg Oncol, Amsterdam, Netherlands
[2] Antoni Van Leeuwenhoek Hosp, Netherlands Canc Inst, Dept Thorac Oncol, Amsterdam, Netherlands
[3] Antoni Van Leeuwenhoek Hosp, Netherlands Canc Inst, Dept Radiotherapy, Amsterdam, Netherlands
[4] Antoni Van Leeuwenhoek Hosp, Netherlands Canc Inst, Dept Pathol, Amsterdam, Netherlands
关键词
D O I
10.1200/JCO.2008.16.3709
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
[No abstract available]
引用
收藏
页码:4205 / 4207
页数:3
相关论文
共 1 条
  • [1] EGFR and KRAS mutations as criteria for treatment with tyrosine kinase inhibitors: retro- and prospective observations in non-small-cell lung cancer
    van Zandwijk, N.
    Mathy, A.
    Boerrigter, L.
    Ruijter, H.
    Tielen, I.
    de Jong, D.
    Baas, P.
    Burgers, S.
    Nederlof, P.
    [J]. ANNALS OF ONCOLOGY, 2007, 18 (01) : 99 - 103